Table 4 Clinical characteristics of COPD patients at baseline
SCOPD | AECOPD | P value | |
|---|---|---|---|
n | 42 | 55 | |
Duration of COPD, years¥ | 3 (3) | 5.5 (7) | < 0.001 |
Cor pulmonale, n (%) | 3 (7) | 22 (50) | < 0.001 |
Home oxygen therapy, n (%) | 7 (17) | 42 (76) | < 0.001 |
Exacerbation history¥ | 1 (1) | 3 (2) | < 0.001 |
Hospitalizations¥ | 0 (1) | 2 (2) | < 0.001 |
Complications, n (%) | |||
Cardiovascular disease | 4 (10) | 4 (7) | 0.724 |
Hypertension | 7 (7) | 7 (12) | 0.772 |
Diabetes | 1 (2) | 7 (13) | 0.132 |
mMRC dyspnoea score, n (%) | < 0.001 | ||
0 | 3 (7) | 0 (0) | |
1 | 13 (31) | 0 (0) | |
2 | 20 (48) | 5 (9) | |
3 | 6 (14) | 19 (35) | |
4 | 0 (0) | 31 (56) | |
CAT score | 13.12 ± 5.74 | 24.60 ± 4.74 | < 0.001 |
Using inhaled drugs n (%) | |||
LAMA | 36 (86) | 39 (60) | 0.005 |
LABA/ICS | 18 (43) | 36 (66) | 0.039 |
LAMA + LABA/ICS | 15 (36) | 25 (46) | 0.407 |